Evidence map›Paper›PMID 35879950›Full record

ArticleJournal of immunology research2022

Flavokawain B Weakens Gastric Cancer Progression via the TGF-

Yongzhao Zhu, Weining Fan, Yuanzhen Wang, Huan Ding, Shaoqi Yang, Fang He

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of immunology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. A Novel Tri-Hydroxy-Methylated Chalcone Isolated fromInternational journal of molecular sciences · 2023
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yongzhao ZhuGeneral Hospital of Ningxia Medical University, Yinchuan, 750004 Ningxia, China.
Weining FanGeneral Hospital of Ningxia Medical University, Yinchuan, 750004 Ningxia, China.
Yuanzhen WangGeneral Hospital of Ningxia Medical University, Yinchuan, 750004 Ningxia, China.
Huan DingGeneral Hospital of Ningxia Medical University, Yinchuan, 750004 Ningxia, China.
Shaoqi YangGeneral Hospital of Ningxia Medical University, Yinchuan, 750004 Ningxia, China.ORCID https://orcid.org/0000-0002-4377-1978
Fang HeGeneral Hospital of Ningxia Medical University, Yinchuan, 750004 Ningxia, China.ORCID https://orcid.org/0000-0002-4312-7517
Ningxia Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was designed to observe the treatment effects of flavokawain B (FKB) on gastric cancer both in SGC-7901 cells and nude mice. When SGC-7901 cells were exposed to 10

Indexed as

ApoptosisStomach NeoplasmsAnimalsCarcinogenesisCell Line, TumorCell ProliferationFlavonoidsG2 Phase Cell Cycle CheckpointsHumansMacrophagesMiceMice, NudeSmad4 ProteinTransforming Growth Factor beta1flavokawain BFlavonoidsSmad4 ProteinSMAD4 protein, humanTGFB1 protein, humanTransforming Growth Factor beta1

Identifiers

PMID35879950
PMCPMC9308533
OpenAlexW4285588802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.